Luigi Manenti
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 3
- CAR-T cell therapy research 2
- Immunology top 10%
- Physiology top 5%
- Adenosine and Purinergic Signaling 2
- Cancer Research top 10%
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 2
-
- Barrier Structure and Function Studies 2
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Raffaella GiavazziAngela GarofaloDorina BelottiSergio MarchiniGiulia TarabolettiGiuseppe CuriglianoToshihiko DoiArmando Santoro
- Cited by
- OncologyImmunologyPhysiology
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Luigi Manenti
18 papers receiving 876 citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 470
- Immunology 284
- Physiology 54
- Cancer Research 171
- Reproductive Medicine 65
Countries citing papers authored by Luigi Manenti
This map shows the geographic impact of Luigi Manenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Manenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Manenti more than expected).
Fields of papers citing papers by Luigi Manenti
This network shows the impact of papers produced by Luigi Manenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Manenti. The network helps show where Luigi Manenti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luigi Manenti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 50 | |
| 7 | 2022 | 5 | |
| 8 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumorsbreakdown → | 2021 | 257 |
| 9 | 2019 | 32 | |
| 10 | 2019 | 2 | |
| 11 | 2018 | 37 | |
| 12 | 2016 | 8 | |
| 13 | 2013 | 22 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 4 | |
| 16 | 2011 | 67 | |
| 17 | 2005 | 25 | |
| 18 | 2004 | 46 | |
| 19 | Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. | 2003 | 273 |
| 20 | The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically. | 2003 | 52 |
About Luigi Manenti
Luigi Manenti is a scholar working on Physiology, Oncology, Neurology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 886 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (3 papers), CAR-T cell therapy research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Adenosine and Purinergic Signaling (2 papers), Barrier Structure and Function Studies (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Oncology (470 citations), Immunology (284 citations), Physiology (54 citations), Cancer Research (171 citations) and Reproductive Medicine (65 citations). Luigi Manenti has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Raffaella Giavazzi, Angela Garofalo, Dorina Belotti, Sergio Marchini, Giulia Taraboletti, Giuseppe Curigliano, Toshihiko Doi, Armando Santoro, Tyler A. Longmire and John Sarantopoulos. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.